Table 4.
Comparison of metabolic syndrome and its components in HIV-infected patients on HAART with and without IR
| Metabolic syndrome’s components | Total (n = 219) | No IR (n = 144) | IR (n = 75) | PR | P |
|---|---|---|---|---|---|
| Metabolic Syndrome, n (%) | 59 (26.9) | 26 (18.1) | 33 (44.0) | 2.131 | <0.001 |
| Central Obesity, n (%) | 49 (22.4) | 25 (17.4) | 24 (32.0) | 1.633 | 0.007 |
| Hypertriglyceridemia, n (%) | 106 (48.4) | 66 (45.8) | 40 (53.3) | 1.218 | 0.297 |
| Low HDL-C, n (%) | 126 (57.5) | 81 (56.3) | 45 (60.0) | 1.107 | 0.600 |
| Hyperglycemia, n (%) | 103 (47.0) | 58 (40.3) | 45 (60.6) | 1.689 | 0.008 |
| 100−125 g/dL | 94 (42.9) | 57 (39.6) | 37 (49.3) | 1.86 | 0.038 |
| > 125 g/dL | 9 (4.1) | 1 (0.7) | 8 (10.7) | 2.75 | 0.004 |
| High Blood Pressure, n (%) | 8 (3.7) | 4 (2.8) | 4 (5.3) | 1.486 | 0.258 |
Abbreviations: HDL-C high-density lipoprotein cholesterol, IR insulin resistance